Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$32.25
−$1.39 · -4.13%
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Previous close
$32.25
−$1.39 · -4.13%
After-hours
$32.25
$0.00 · 0.00%
Sep 10, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Day range
Current $32.25
52-week range
Current $32.25
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
51
Fair Value
Sentiment
73
Bullish
Risk
41
Elevated Risk
Momentum
57
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Day range
Current $32.25
52-week range
Current $32.25
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.18B USD | 1.11B USD | 1.15B USD | 1.3B USD | 1.13B USD |
| Cost of goods sold | 676.8M USD | 641.24M USD | 647.18M USD | 706.96M USD | 577.37M USD |
| Gross profit | 508.04M USD | 471M USD | 499.93M USD | 588.99M USD | 554.65M USD |
| Research and development | 87.74M USD | 90.41M USD | 93.29M USD | 104.97M USD | 75.72M USD |
| Selling, general, and administrative | 408.64M USD | 380.25M USD | 425.97M USD | 486.34M USD | 389.43M USD |
| Operating expenses | 496.38M USD | 470.67M USD | 519.26M USD | 591.31M USD | 465.15M USD |
| Interest income | 11.9M USD | 24.9M USD | 14.76M USD | — | — |
| Interest expense | 3.91M USD | 4.53M USD | — | 130K USD | 22.39M USD |
| Depreciation and amortization | 86.63M USD | 89.76M USD | 95.56M USD | 99.17M USD | 84.93M USD |
| Operating income | 11.67M USD | 337K USD | −19.33M USD | −2.32M USD | 89.51M USD |
| Net income | 2.05M USD | 12.53M USD | −20.37M USD | 5.65M USD | 77.85M USD |
Company facts updated Sep 11, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$57.50
78.29% upsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR99.81M0.09%107.03B USD0.06%$141.44-0.88%
Vanguard Morningstar Total Stock Market ETFVTI48.62M0.00%2.3T USD0.03%$373.24-0.62%
iShares Russell 2000 ETFIWM39.06M0.05%77.55B USD0.19%$287.7-1.01%
Vanguard Morningstar Small-Cap ETFVB35.15M0.02%183.4B USD0.03%$291.18-0.99%
Vanguard Morningstar Small-Cap Value ETFVBR22.31M0.03%68.3B USD0.05%$240.25-0.68%
Vanguard Extended Market ETFVXF18.56M0.02%93.7B USD0.05%$236.16-1.05%
iShares S&P Small-Cap 600 Value ETFIJS14.65M0.17%8.07B USD0.18%$133.9-0.84%
iShares Russell 2000 Value ETFIWN14.31M0.10%14.28B USD0.24%$218.97-0.68%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFiShares S&P Small-Cap 600 Value ETFIJSiShares Russell 2000 Value ETFIWNAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
